Pages that link to "Q42689180"
Jump to navigation
Jump to search
The following pages link to Irinotecan: a new antineoplastic agent for the management of colorectal cancer (Q42689180):
Displaying 8 items.
- Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile (Q33370478) (← links)
- High antimetastatic efficacy of MEN4901/T-0128, a novel camptothecin carboxymethyldextran conjugate (Q34432610) (← links)
- Natural products as leads to anticancer drugs (Q34730142) (← links)
- Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan (Q36551126) (← links)
- Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients (Q36990461) (← links)
- UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicity. (Q37158174) (← links)
- Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression (Q43288450) (← links)
- Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin (Q44593849) (← links)